• Giant Cell Arteritis: What a Long Strange Trip It Has Been

    3 monthes ago - By Healio

    In this issue of Healio Rheumatology, we feature an update on giant cell arteritis as provided by a panel of experts, which charges me with excitement about a disease that continues to challenge us. I thought for some time about what to say about giant cell arteritis in this Editorial, and all I could do was mull over the twisting and turning history of this form of vasculitis that continues to fascinate us.Aside from the ancients, who no doubt encountered and described the condition, giant cell arteritis was first well-described by the medical polymath Sir Jonathan Hutchinson, who in 1890...
    Read more ...

     

  • Closer Look at Giant Cell Arteritis

    3 monthes ago - By Healio

    At last year's American College of Rheumatology Annual Meeting, preliminary results of the GiACTA study made a splash among clinicians who deal with giant cell arteritis. The findings offered tangible hope that tocilizumab might be the next step in GCA therapy that rheumatologists have been looking for since prednisone hit the market some 70 years ago.“We have not identified an effective steroid-sparing medication since prednisone became the standard of therapy in the 1950s,” Kenneth J. Warrington, MD, professor of Medicine and chair of the Division of Rheumatology at the Mayo Clinic in...
    Read more ...